Sionna Therapeutics, Inc. (SION) News
Track canonical SquawkNews coverage tagged to SION, Sionna Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 Results
U.S. stocks traded mostly lower this morning, with the Dow Jones index falling around 0.2% on Monday. Following the market opening Monday, the Dow traded down 0.16% to 53,949.06 while the NASDAQ fell 0.07% to 26,672.55.
EARNINGS | Aug 10, 2026, 01:40 PM UTC
L
SION - Sionna Therapeutics Reports Second Quarter 2026 Financial Results
SION - Sionna Therapeutics Reports Second Quarter 2026 Financial Results
EARNINGS | Aug 06, 2026, 11:00 AM UTC
L
SION Maintain Buy and $50 PT ahead of he upcoming Phase II Precision readout in the next 2-4 weeks @ GUGG
SION Maintain Buy and $50 PT ahead of he upcoming Phase II Precision readout in the next 2-4 weeks @ GUGG
EQUITY | Jul 27, 2026, 01:12 PM UTC
L
Sionna Therapeutics Insider Sold Shares Worth $3,854,281, According to a Recent SEC Filing
() -- Peter A. Thompson, Director, on July 07, 2026, sold 85,918 shares in Sionna Therapeutics (SION) for $3,854,281. Following the Form 4 filing with the SEC, Thompson has control over a total of 2,469,959 common shares
REGULATION | Jul 09, 2026, 08:54 PM UTC
L
Sionna Therapeutics Insider Sold Shares Worth $446,862, According to a Recent SEC Filing
() -- Jennifer Fitzpatrick, Chief Legal Officer, on July 06, 2026, sold 10,250 shares in Sionna Therapeutics (SION) for $446,862. SEC Filing: Copyright © 2026. All rights reserved. does not provide investment advice. Una
REGULATION | Jul 07, 2026, 08:42 PM UTC